Endocyte, Inc. (ECYT) Financial Analysis & Valuation | Quarter Chart
Endocyte, Inc. (ECYT)
ECYTPrice: $23.99
Fair Value: 🔒
🔒score
Description
Shares
| Market Cap | $0 | Exchange | NASDAQ |
| Sector | — | Industry | — |
| Country | — | CEO | — |
| IPO Date | 2011-02-04 | CAGR | -0.2% |
| Employees | — | Website | — |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
ECYT chart loading...
Fundamentals
Technicals
| Enterprise Value | $1.21B | P/E Ratio | — |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | — | P/B Ratio | 11.03 |
| P/CF Ratio | -31.29 | P/FCF Ratio | — |
| EPS | — | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 83.82% | Gross Margin | 1% |
| Operating Margin | -801.51% | Profit Margin | -1008.02% |
| ROE | -0.61% | ROA | -0.7% |
| ROCE | -0.58% | Current Ratio | 21.68 |
| Quick Ratio | 21.52 | Cash Ratio | 4.08 |
| Debt/Equity | — | Interest Coverage | — |
| Altman Z Score | — | Piotroski Score | — |